Autologous T-cells Genetically Engineered to Express Receptors Reactive Against KRAS Mutations in Conjunction With a Vaccine Directed Against These Antigens in Participants With Metastatic Cancer
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
University of Southern California
National Institutes of Health Clinical Center (CC)
Rutgers, The State University of New Jersey
Fate Therapeutics
Fate Therapeutics
PACT Pharma, Inc.
Masonic Cancer Center, University of Minnesota
Barbara Ann Karmanos Cancer Institute
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Cancer Research UK